Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compugen (CGEN) Common Equity (2018 - 2025)

Compugen's Common Equity history spans 13 years, with the latest figure at $102.7 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 87.08% to $102.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $102.7 million, a 87.08% increase, with the full-year FY2025 number at $102.7 million, up 87.08% from a year prior.
  • Common Equity hit $102.7 million in Q4 2025 for Compugen, up from $54.9 million in the prior quarter.
  • Over the last five years, Common Equity for CGEN hit a ceiling of $106.7 million in Q4 2021 and a floor of $54.9 million in Q4 2024.
  • Historically, Common Equity has averaged $81.5 million across 5 years, with a median of $77.7 million in 2022.
  • Biggest five-year swings in Common Equity: dropped 27.19% in 2022 and later skyrocketed 87.08% in 2025.
  • Tracing CGEN's Common Equity over 5 years: stood at $106.7 million in 2021, then dropped by 27.19% to $77.7 million in 2022, then decreased by 15.6% to $65.6 million in 2023, then dropped by 16.24% to $54.9 million in 2024, then surged by 87.08% to $102.7 million in 2025.
  • Business Quant data shows Common Equity for CGEN at $102.7 million in Q4 2025, $54.9 million in Q4 2024, and $65.6 million in Q4 2023.